Retrospective Analysis of the Management of Kaposi’s Sarcoma: Single-Center Experience |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.13, No. 4)Publication Date: 2021-07-07
Authors : R EL Hazzaz; K Oualla; K Darif; H Erraichi; S Berrad; L Nouiyekh; L Amaadour; Z Benbrahim; S Arifi; N Mellas;
Page : 323-327
Keywords : Sarcoma; Kaposi; Chemotherapy; Radiotherapy; Retrospective;
Abstract
Introduction: Kaposi's sarcoma (MK) is most likely caused by human herpes virus type 8 (HHV-8) which develops particularly in individuals infected with HIV. This disease causes purplish or brownish tumors on the skin. Other organs can be affected, such as the mucous membranes, and the viscera. The goal of our study is to describe the epidemiological, clinical and therapeutic profile of this disease. Chemotherapy has big interest in Kaposi sarcoma.
Other Latest Articles
- The Periodontal Ligament, A Key Factor During Orthodontic Tooth Movement: Mechanical Characterization by Nanoindentation |Biomedgrid
- Influence of the Cooling Rate of Silica Glass on Its Surface Relief |Biomedgrid
- Child In 2020: Reduced Physical Activity What Are the Repercussions? |Biomedgrid
- An mRNA-Binding Protein of The Ancient Protist Trichomonas Vaginalis |Biomedgrid
- Structural, Spectroscopic, Thermal, and Biological Studies of New Schiff Base Ligand Derived from Anthrone and 3-Amino-1-Phenyl-2-Pyrazoline-5-One and Its Complexes with Metallic Ions
Last modified: 2023-09-20 22:09:57